Brief: Theranexus, CRNL And CERMEP Create New Laboratory
Dec 18 (Reuters) - Theranexus SA ALTHX.PA :
* THERANEXUS, LYON NEUROSCIENCE RESEARCH CENTER (CRNL) AND
CERMEP
ANNOUNCE CREATION AND FUNDING OF NEW JOINT PUBLIC/PRIVATE
LABORATORY "NEUROIMAGING FOR DRUG DISCOVERY" (NI2D)
* THIS PROJECT IS SUPPORTED BY FUNDING OF EUR 350,000 FROM
FRENCH
NATIONAL RESEARCH AGENCY, WHICH COMES IN ADDITION TO EUR 200,000
ALREADY OBTAINED FROM AUVERGNE-RHÔNE-ALPES REGION
Source text for Eikon: ID:nACT66542
Further company coverage: ALTHX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease